Tetrylammonium

Tetrylammonium

SCHEMBL4331841

CCC(c1ccccc1)C(OB([O-])O)(c1ccccc1)c1ccccc1.CC[N+](CC)(CC)CC

nearest known ligand 0.35

Full drug profile on Sugi Atlas →

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 2/20 0.35
CHRM1 P11229 2/20 0.35
CHRM3 P20309 1/20 0.35
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
TSHR P16473 1/20 0.34
CYP2C19 P33261 1/20 0.34
LMNA P02545 2/20 0.33
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
POLB P06746 1/20 0.31
HKDC1 Q2TB90 1/20 0.31
CYP2D6 P10635 1/20 0.30
KCNH2 Q12809 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tetramethylammonium Ion SCHEMBL2428732 0.92 LMNA (0.34) CHRM2CHRM1CHRM3CYP1A2CYP3A4
Tetrylammonium SCHEMBL9812209 0.89 CHRM2 (0.33) CHRM2CHRM1CHRM3CYP1A2CYP3A4
Tetrylammonium SCHEMBL4331836 0.89 CHRM1 (0.36) CHRM2CHRM1CHRM3CYP1A2CYP3A4
Tetrabuthylammonium SCHEMBL1350364 0.88 MEN1 (0.34) CHRM2CHRM1CHRM3CYP3A4LMNA
SCHEMBL8350821 0.87 MEN1 (0.35) CHRM2CHRM1CHRM3CYP3A4LMNA
Choline SCHEMBL9015249 0.85 SCN1A (0.34) CHRM2CHRM1CHRM3
Tetrylammonium SCHEMBL3361503 0.85
SCHEMBL9685838 0.82 CHRM2 (0.32) CHRM2CHRM1CHRM3
Tetrylammonium SCHEMBL3361103 0.82 EDNRB (0.31)
Cetrimonium SCHEMBL9771961 0.82 CHRM2 (0.36) CHRM2CHRM1CHRM3CYP3A4LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118119658-A Composition for forming conductive elastomer, and polymer 大阪有机化学工业株式会社 2024-05-31 CN disclosed
CN-110662774-A (meth) acrylic resin and method for adjusting strain thereof 大阪有机化学工业株式会社 2020-01-07 CN disclosed
US-20090142672-A1 OPTICAL RECORDING COMPOSITION AND HOLOGRAPHIC RECORDING MEDIUM FUJIFILM CORPORATION (JP) 2009-06-04 US disclosed
US-20080261118-A1 OPTICAL RECORDING COMPOSITION AND HOLOGRAPHIC RECORDING MEDIUM FUJIFILM CORPORATION (JP) 2008-10-23 US disclosed
US-7371466-B2 Polymerisation initiators, polymerisable compositions, and uses thereof for bonding low surface energy substrates LOCTITE (R & D) LIMITED (IE) 2008-05-13 US disclosed
US-7267886-B2 Polymerisation initiators, polymerisable compositions, and uses thereof for bonding low surface energy substrates LOCTITE (R&D) LIMITED (IE) 2007-09-11 US disclosed
US-7189463-B2 Polymerisation initiators, polymerisable compositions, and uses thereof for bonding low surface energy substrates LOCTITE (R&D) LIMITED (IE) 2007-03-13 US disclosed
US-20050154160-A1 Polymerisation initiators, polymerisable compositions, and uses thereof for bonding low surface energy substrates LOCTITE (R&D) LIMITED 2005-07-14 US disclosed
EP-1328597-B1 QUATERNARY BORON COMPOUND POLYMERISATION INITIATORS, POLYMERISABLE COMPOSITIONS AND USES THEREOF FOR BONDING LOW SURFACE ENERGY SUBSTRATES LOCTITE R & D LTD (IE) 2005-03-02 EP disclosed
US-20040068067-A1 Quratenary boron compound polymerisation initiators, polymerisable compositions, and uses thereof for bonding low surface energy substrates Henkel IP & Holding GmbH (DE) 2004-04-08 US disclosed
EP-1328597-A1 QUATERNARY BORON COMPOUND POLYMERISATION INITIATORS, POLYMERISABLE COMPOSITIONS AND USES THEREOF FOR BONDING LOW SURFACE ENERGY SUBSTRATES Loctite (R & D) Limited (IE) 2003-07-23 EP disclosed
WO-2002034851-A1 QUATERNARY BORON COMPOUND POLYMERISATION INITIATORS, POLYMERISABLE COMPOSITIONS, AND USES THEREOF FOR BONDING LOW SURFACE ENERGY SUBSTRATES LOCTITE (R & D) LIMITED (IE) 2002-05-02 WO disclosed
US-5854298-A Photocurable low observable aircraft materials LOCKHEED MARTIN CORPORATION (US) 1998-12-29 US disclosed
EP-0387087-B1 Photoinitiator compositions, photohardenable compositions and photosensitive microcapsules CYCOLOR INC (US) 1997-10-08 EP disclosed
US-5230982-A Heterocyclic disulfides for crosslinking THE MEAD CORPORATION (US) 1993-07-27 US disclosed
US-5153100-A Hexaarylbisimidazole and-or p-dialkylaminophenyl carbonyl compound E. I. DU PONT DE NEMOURS AND COMPANY (US) 1992-10-06 US disclosed
EP-0475153-A1 Borate coinitiators for photopolymerizable compositions E.I. DU PONT DE NEMOURS AND COMPANY (US) 1992-03-18 EP disclosed
EP-0387086-A2 Photoinitiator compositions, photohardenable compositions containing the same THE MEAD CORPORATION (US) 1990-09-12 EP disclosed
EP-0387087-A2 Photoinitiator compositions, photohardenable compositions and photosensitive microcapsules THE MEAD CORPORATION (US) 1990-09-12 EP disclosed
US-4954415-A Photoresists, photolithography THE MEAD CORPORATION (US) 1990-09-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090142672-A1 OPTICAL RECORDING COMPOSITION AND HOLOGRAPHIC RECORDING MEDIUM CRY1, CRY2, CACNA1B CHRM2 201/4885CHRM1 77/4885CHRM3 352/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.